Low density lipoprotein for cytotoxic drug targeting: improved activity of elliptinium derivative against B16 melanoma in mice.

Significant low density lipoprotein (LDL) uptake by tumour cells led to the use of LDL as a discriminatory vehicle for the delivery of cytotoxic drugs. In the current study, the lipophilic elliptinium derivative, elliptinium-oleate (OL-NME), was incorporated into LDL to reach an incorporation level...

Descripción completa

Detalles Bibliográficos
Autores principales: Samadi-Baboli, M., Favre, G., Canal, P., Soula, G.
Formato: Texto
Lenguaje:English
Publicado: Nature Publishing Group 1993
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1968583/
https://www.ncbi.nlm.nih.gov/pubmed/8347487

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1968583/
https://www.ncbi.nlm.nih.gov/pubmed/8347487

Ejemplares similares